Kim D Blickenstaff has an estimated net worth of $182 Million. This is based on reported shares across multiple companies, which include DEXCOM INC, Nuvation Bio Inc., TANDEM DIABETES CARE INC, Opy Acquisition Corp. I, MEDIVATION, INC., SENORX INC, and BIOSITE INC.
2005 was Kim D Blickenstaff's most active year for acquiring shares with 50 total transactions. Kim D Blickenstaff's most active month to acquire stocks was the month of January. 2005 was Kim D Blickenstaff's most active year for disposing of shares, totalling 218 transactions. Kim D Blickenstaff's most active month to dispose stocks was the month of January. 2020 saw Kim D Blickenstaff paying a total of $11,007,951.79 for 639,363 shares, this is the most they've acquired in one year. In 2007 Kim D Blickenstaff cashed out on 679,833 shares for a total of $22,387,035.00, their largest year based on trade value.